CytRx Corp.
Edit Page
Report
Scan day: 12 February 2014 UTC
53
Virus safety - good
Description: Biopharmaceutical company specializing in oncology. (NASDAQ: CYTR)
Strong pipeline with proven leadership. CytRx Corporation (NASDAQ: CYTR), is a biopharmaceutical research and development company specializing in oncology. The CytRx oncology pipeline is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic agent doxorubicin. CytRx recently announced highly positive top-line progression-free survival data from its global Phase 2b clinical trial as a treatment for soft tissue sarcomas, has completed its Phase 1b/2 clinical trial primarily in the same indication, and has initiated a Phase 1b pharmacokinetics clinical trial in patients with metastatic solid tumors and a Phase 1b study of aldoxorubicin in combination with doxorubicin in patients with advanced solid tumors. The Company is initiating a Phase 3 pivotal trial under a special protocol assessment (SPA) with aldoxorubicin as a therapy for patients with soft tissue sarcomas whose tumors have progressed following treatment with chemotherapy. CytRx is expanding its pipeline of oncology candidates based on a novel linker platform technology that can be utilized with multiple chemotherapeutic agents and could allow for greater concentration of drug at tumor sites. The Company also has rights to two additional drug candidates, tamibarotene and bafetinib. The Company completed its evaluation of bafetinib in the ENABLE Phase 2 clinical trial in high-risk B-cell chronic lymphocytic leukemia (B-CLL), and plans to seek a partner for further development of bafetinib, and is evaluating further development of tamibarotene.
Size: 1609 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
Page title: | CytRx |
Keywords: | |
Description: | Cytrx corporate website |
IP-address: | 208.72.242.146 |
WHOIS Info
NS | Name Server: NS97.WORLDNIC.COM Name Server: NS98.WORLDNIC.COM |
WHOIS | Status: clientTransferProhibited |
Date | Creation Date: 22-may-1995 Expiration Date: 23-may-2020 |